The tweet was deleted by the author.
But we saved everything 🙂.
Myriad Genetics is set to introduce the FirstGene Multiple Prenatal Screen at an industry-hosted symposium in Washington, D.C. on Sunday, May 3.
The session will focus on how this single-draw prenatal test can assess multiple genetic risks simultaneously. Myriad Genetics positions the product as a technological advancement in prenatal screening, highlighting the integration of various technologies for comprehensive genetic risk detection. Attendees can expect insights into the benefits of streamlined testing through emerging medical technology.
Earlier this year, Myriad Genetics was ranked by Forbes among America's best employers for company culture in 2026 based on employee feedback. The company's workplace recognition follows a period of expansion in its genetic testing offerings. Myriad continues to develop new products addressing reproductive health and genetic risk assessment.